| Dendritic cell-based vaccines: barriers and opportunities JA Cintolo, J Datta, SJ Mathew, BJ Czerniecki Future oncology 8 (10), 1273-1299, 2012 | 151 | 2012 |
| Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2pos DCIS Independent of Route: Results of Randomized Selection … L Lowenfeld, R Mick, J Datta, S Xu, E Fitzpatrick, CS Fisher, KR Fox, ... Clinical cancer research 23 (12), 2961-2971, 2017 | 140 | 2017 |
| Role of hepatic artery infusion chemotherapy in treatment of initially unresectable colorectal liver metastases: a review J Datta, RR Narayan, NE Kemeny, MI D’Angelica JAMA surgery 154 (8), 768-776, 2019 | 110 | 2019 |
| Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: a propensity score–matched analysis BL Ecker, MT McMillan, J Datta, R Mamtani, BJ Giantonio, DT Dempsey, ... Cancer 122 (5), 693-701, 2016 | 107 | 2016 |
| SMAD4 loss in colorectal cancer patients correlates with recurrence, loss of immune infiltrate, and chemoresistance I Wasserman, LH Lee, S Ogino, MR Marco, C Wu, X Chen, J Datta, ... Clinical Cancer Research 25 (6), 1948-1956, 2019 | 90 | 2019 |
| Neoadjuvant therapy for gastric cancer: current evidence and future directions AD Newton, J Datta, A Loaiza-Bonilla, GC Karakousis, RE Roses Journal of gastrointestinal oncology 6 (5), 534, 2015 | 89 | 2015 |
| Optimizing dendritic cell-based approaches for cancer immunotherapy J Datta, JH Terhune, L Lowenfeld, JA Cintolo, S Xu, RE Roses, ... The Yale journal of biology and medicine 87 (4), 491, 2014 | 84 | 2014 |
| Progressive loss of anti-HER2 CD4+ T-helper type 1 response in breast tumorigenesis and the potential for immune restoration J Datta, C Rosemblit, E Berk, L Showalter, P Namjoshi, R Mick, KP Lee, ... Oncoimmunology 4 (10), e1022301, 2015 | 74 | 2015 |
| Nucleocytoplasmic shuttling of the retinoblastoma tumor suppressor protein via Cdk phosphorylation-dependent nuclear export W Jiao, J Datta, HM Lin, M Dundr, SG Rane Journal of Biological Chemistry 281 (49), 38098-38108, 2006 | 73 | 2006 |
| Association of depressed anti-HER2 T-helper type 1 response with recurrence in patients with completely treated HER2-positive breast cancer: role for immune monitoring J Datta, M Fracol, MT McMillan, E Berk, S Xu, N Goodman, DA Lewis, ... JAMA oncology 2 (2), 242-246, 2016 | 71 | 2016 |
| Anti-HER2 CD4+ T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer J Datta, E Berk, S Xu, E Fitzpatrick, C Rosemblit, L Lowenfeld, ... Breast Cancer Research 17, 1-15, 2015 | 71 | 2015 |
| Disentangling the association between statins, cholesterol, and colorectal cancer: a nested case-control study R Mamtani, JD Lewis, FI Scott, T Ahmad, DS Goldberg, J Datta, YX Yang, ... PLoS medicine 13 (4), e1002007, 2016 | 67 | 2016 |
| Coaltered Ras/B-raf and TP53 is associated with extremes of survivorship and distinct patterns of metastasis in patients with metastatic colorectal cancer J Datta, JJ Smith, WK Chatila, JC McAuliffe, C Kandoth, E Vakiani, ... Clinical Cancer Research 26 (5), 1077-1085, 2020 | 66 | 2020 |
| Implications of inadequate lymph node staging in resectable gastric cancer: A contemporary analysis using the N ational C ancer D ata B ase J Datta, RS Lewis Jr, R Mamtani, D Stripp, RR Kelz, JA Drebin, DL Fraker, ... Cancer 120 (18), 2855-2865, 2014 | 65 | 2014 |
| Radiation as immunomodulator: implications for dendritic cell-based immunotherapy RE Roses, J Datta, BJ Czerniecki Radiation research 182 (2), 211-218, 2014 | 58 | 2014 |
| Aberrant nucleocytoplasmic localization of the retinoblastoma tumor suppressor protein in human cancer correlates with moderate/poor tumor differentiation W Jiao, HM Lin, J Datta, T Braunschweig, JY Chung, SM Hewitt, SG Rane Oncogene 27 (22), 3156-3164, 2008 | 57 | 2008 |
| Combined MEK and STAT3 inhibition uncovers stromal plasticity by enriching for cancer-associated fibroblasts with mesenchymal stem cell-like features to overcome immunotherapy … J Datta, X Dai, A Bianchi, IDC Silva, S Mehra, VT Garrido, P Lamichhane, ... Gastroenterology 163 (6), 1593-1612, 2022 | 53 | 2022 |
| Prognosis of patients with melanoma and microsatellitosis undergoing sentinel lymph node biopsy EK Bartlett, M Gupta, J Datta, PA Gimotty, DP Guerry, X Xu, DE Elder, ... Annals of surgical oncology 21, 1016-1023, 2014 | 51 | 2014 |
| Rationale for a multimodality strategy to enhance the efficacy of dendritic cell-based cancer immunotherapy J Datta, E Berk, JA Cintolo, S Xu, RE Roses, BJ Czerniecki Frontiers in Immunology 6, 271. doi: 10.3389/fimmu.2015.00271, 2015 | 47 | 2015 |
| Surgical management of adrenocortical carcinoma: an evidence-based approach J Datta, RE Roses Surgical Oncology Clinics 25 (1), 153-170, 2016 | 43 | 2016 |
Matthew Tate McMillanMemorial Sloan Kettering Cancer CenterGeverifieerd e-mailadres voor mskcc.org
